|
|
40
|
|
|
B4813
|
|
|
VYMADA 97MG | 103MG TAB (NVS/COL) SACUBITRIL | VALSARTAN
|
|
|
SACUBITRIL|VALSARTAN
|
|
|
VYMADA
|
|
|
28'S
|
|
|
B
|
|
|
70.68
|
|
|
2.52
|
|
|
97MG|103MG
|
|
|
TABLET
|
|
|
0
|
|
|
TAB
|
|
|
NVS
|
|
|
NOVARTIS CARIBE SA
|
|
|
COL
|
|
|
COLLINS LTD
|
|
|
|
|
|
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
No
|
|
|
243208
|
|
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
|
|
|
|
|
Oral
|
|
|
6
|
|
|
CARDIOVASCULAR DRUGS
|
|
|
|